Clin2
NCT07733934Possibly a fitNot yet recruiting

Teverelix for enlarged prostate and sudden urinary retention

Acute Urinary RetentionBenign Prostate Hypertrophy(BPH)

Part of Kidney & urinary clinical trials.

This study tests a medication called teverelix that may help shrink an enlarged prostate and improve urinary function after a sudden inability to urinate. It aims to reduce the chances of needing surgery or a catheter again.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
126 people
Ages
45 years and older
Study type
Interventional

Who can take part

  • You must be a man aged 45 or older.
  • You must have recently (within the last 6 days) had a sudden inability to urinate (acute urinary retention) for the first time.
  • You must have been able to urinate successfully after having a catheter removed (a trial without catheter).
  • Your prostate must be enlarged, weighing more than 40 grams (about the size of a walnut or larger).
  • You must not have had prostate cancer or prostate/urethral surgery before.
  • You must not have taken certain medications (like anti-androgens or testosterone) within the past 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07650968Recruiting· Phase 4
Prostate Medication Adjustment After Sudden Inability to Urinate

This trial tests whether increasing your prostate medication (tamsulosin) or switching to a different medication (silodosin) helps you urinate normally again after a sudden blockage caused by an enlarged prostate. The goal is to help you avoid long-term catheter use.

Banī Suwayf, Beni Suweif Governorate
NCT07654413Recruiting· Phase 4
Tamsulosin with or without tadalafil for catheter removal after urinary retention

This trial tests whether adding tadalafil to tamsulosin helps men pass a catheter removal test after a first-time urinary blockage caused by an enlarged prostate. The goal is to find which treatment works best to avoid needing a catheter again.

Banī Suwayf, Beni Suweif Governorate
NCT07276919Not yet recruiting· Phase 4
Tamsulosin after prostate biopsy to improve urination

This trial tests whether giving tamsulosin (a medicine that helps relax urine flow) around the time of a prostate biopsy can improve urination problems that sometimes happen after the biopsy. It may help you avoid discomfort and bladder issues after the procedure.

Beijing, Outside U.S./Canada
NCT07457164Not yet recruiting· Phase 2
New hormone therapy for advanced prostate cancer

This study tests a new injectable medication (teverelix DP) that lowers a hormone called testosterone to help control advanced prostate cancer. It is for men who haven't had hormone therapy before and who are otherwise relatively healthy.

NCT07870759Not yet recruiting· Phase 3
Combination therapy for enlarged prostate symptoms

This trial tests whether combining two medicines works better than one alone for easing urinary symptoms caused by an enlarged prostate. If you have bothersome symptoms and a larger prostate, this study may help you find a more effective treatment.

NCT06546735Not yet recruiting· Phase 3
Combination treatment for frequent urination due to enlarged prostate

This study tests a combination of two medicines in a single pill to see if they work better together to reduce frequent urination and sudden urges in men with an enlarged prostate. The goal is to improve quality of life by easing these bothersome symptoms.

São Paulo, São Paulo

Hear when a new Acute Urinary Retention trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.